"Reports & Events" is a monthly tip sheet for the news media that highlights selected meetings of interest and reports from the National Academies of Sciences, Engineering, and Medicine.
Selected Events in November 2018
Click on each event's title to access meeting details, an agenda, and registration information, or contact the Office of News and Public Information (202-334-2138 or e-mail email@example.com). Reporters should register for all meetings. More events can be found at http://www8.nationalacademies.org/publicevent/.
Evidence-based Clinical Practice Guidelines for Prescribing Opioids for Acute Pain
Nov. 13 | Washington, D.C.
This is a meeting of a National Academies committee tasked with developing a framework to evaluate the evidence base for existing clinical practice guidelines for prescribing opioids for acute pain indications. The study also will identify surgical procedures and health conditions for which new guidelines should be developed and prioritize a research agenda to address the evidence gaps. U.S. Food and Drug Administration Commissioner Scott Gottlieb will provide opening remarks at this meeting.
Strengthening the Connection Between Health Professions Education and Practice
Nov. 13 and 14 | Washington, D.C.
This workshop, co-hosted with the National Center for Interprofessional Practice and Education, will explore methods for bridging health professions education and practice in ways that improve information flow between learning and application. The event will be webcast.
Multisectoral Engagement in Global Health
Nov. 15 and 16 | Washington, D.C.
This workshop will explore assumptions about the value proposition for engagement between industry and the global health community, examine approaches and policies for multisectoral engagement, discuss barriers to success, and identify ways to enable value creation and the implementation of innovative models. The event will be webcast.
Research on Non-Nutritive Sweeteners
Nov. 16 | Virtual
This one-hour webinar will provide a high-level overview of current and emerging scientific knowledge about potential health outcomes related to the consumption of non-nutritive sweeteners, as well as address current gaps in research.
A Century After the 1918 Flu Pandemic
Nov. 26 | Washington, D.C.
A century after the 1918 flu pandemic wiped out more than 50 million people worldwide, is society still at risk? This event will include a discussion of how we can prepare for the next flu pandemic and prevent a global catastrophe. Featuring a keynote address by Laurie Garrett, Pulitzer Prize-winning journalist and founder of Anthropos Initiative, the event will highlight progress in science, public health, global governance, and cross-sectoral alliances for pandemic flu preparedness. The event will be webcast.
Readiness for Microbial Threats 2030
Nov. 27 and 28 | Washington, D.C.
This workshop will examine the world’s current readiness to prevent, detect, and respond to pandemic influenza and other potential novel diseases. The event will focus on overcoming the structural and behavioral obstacles to achieving greater preparedness, in order to identify short-term actions that will have the greatest impact on global health security by 2030.
Second International Summit on Human Genome Editing
Nov. 27-29 | Hong Kong
Since the first international summit on human genome editing was held in 2015, an explosion of new research is employing CRISPR/Cas9 and other powerful, precise editing tools, and clinical trials are imminent for applications to treat serious diseases. However, questions remain concerning the science, application, ethics, and governance of human genome editing. Co-hosted by the Academy of Sciences of Hong Kong, the Royal Society of London, the U.S. National Academy of Sciences, and the U.S. National Academy of Medicine, the Second International Summit on Human Genome Editing will gather a broad range of stakeholders – including researchers, ethicists, policymakers, clinicians, patient and disability groups, and representatives from science and medical academies and organizations worldwide – to examine the issues. Sessions will be webcast.
Virtual Clinical Trials: Challenges and Opportunities
Nov. 28 and 29 | Washington, D.C.
Clinical trials are a cornerstone of medical product development; they help evaluate the efficacy of new drugs and identify safety issues, and they are a necessary regulatory requirement for bringing novel therapies to market. This workshop will explore opportunities for developing modern, patient-centric clinical trials in light of digital health tools that could allow virtual clinical trials for new medical product approval. The event will be webcast.
Pain and Symptom Management for People with Serious Illness in the Context of the Opioid Epidemic
Nov. 29 | Washington, D.C.
This workshop will explore the tension between efforts to address the opioid epidemic and the resulting impact on access to pain medications for people facing serious illness. It will examine the unintended consequences of the responses to the opioid epidemic for patients, families, communities, and clinicians, and consider potential policy opportunities to address them. The event will be webcast.
Reports Scheduled for Release in November
Release dates for the following consensus reports and proceedings from the Academies depend on successful completion of the review process and publishing schedules. Reporters who would like to be notified when a report is due for release should contact the Office of News and Public Information -- 202-334-2138 or e-mail firstname.lastname@example.org -- and ask to be placed on the contact list.
Gulf War and Health, Volume 11: Generational Health Effects of Serving in the Gulf War
This report assesses the current research available on possible generational health effects that may result from exposures to toxicants experienced by veterans of the 1990-1991 Gulf War during their deployments. The committee considered which toxicants are known to be associated with harmful health and developmental effects in parents, their offspring, and second-generation offspring. The report also assesses the scope and methodology required to conduct research on such descendants to identify health effects.
Veterans and Agent Orange: 11th Update (2018)
This report is the final of the congressionally mandated Veterans and Agent Orange series, which reviews scientific and medical literature on health effects from exposure to herbicides used during the Vietnam War. This update focuses on three health outcomes, including possible generational health effects, that may be the result of herbicide exposure among male Vietnam veterans.
Learning Through Citizen Science: Designing for Impact
Describes existing citizen science projects that seek to support science learning, considers research on science learning in both formal and informal settings, and develops a set of evidence-based principles to guide the design of citizen science projects that have science learning as a goal.
Science and Engineering for Grades 6-12: Investigation and Design at the Center
Reviews research on science investigations and engineering design for middle and high school students conducted since publication of America’s Lab Report (2006) and uses this research to inform the revision of the original report.
ALSO OF INTEREST
Nov. 15 | Washington, D.C.
D.C. Art Science Evening Rendezvous (DASER) is a discussion forum on art science projects, providing a snapshot of the cultural environment of the region and fostering interdisciplinary networking. In November, DASER explores the topic Creating Things that Matter: The Art and Science of Innovations that Last. Registration required
ADDITIONAL RESOURCES FOR REPORTERS